According to a market report by Lucintel, the future of the global cancer biomarkers market looks promising with opportunities in the diagnostics, R&D, prognostics, and risk management markets. The global cancer biomarkers market is expected to reach an estimated $38 billion by 2030 with a CAGR of 14.5% from 2024 to 2030. The major drivers for this market are the increasing inclination towards personalized medicine for cancer treatment, growing awareness towards the importance of early detection of cancer, and rising government support for cancer research.
A more
than 150-page report to understand trends, opportunity and forecast in global cancer
biomarkers market to 2030 by type
(protein, genetic, and others), cancer type (lung, breast, leukemia, melanoma,
colorectal, prostate, thyroid, kidney, and others), profiling technology (omics,
imaging, immunoassay, bioinformatics, and others), application (diagnostics,
R&D, prognostics, risk management, and others), and region (North America,
Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that, within the cancer type category, breast cancer will remain the
largest segment over the forecast period due to the increasing incidence of
breast cancer and rising awareness of the diagnosis of this disease.
Within the
application category, the diagnostic will remain the largest segment due to the
increasing prevalence of cancer and the growing availability of cancer
screening programs.
Download
sample by clicking on cancer biomarkers
market.
In terms
of regions, North America will remain the largest region during the forecast
period due to the presence of well-established healthcare systems, rising
incidence of cancer, and easy accessibility to advanced healthcare technologies
in the region.
F.
Hoffmann-La Roche, Thermo Fisher Scientific, Illumina, QIAGEN N.V., Bio-Rad
Laboratories are the major suppliers in the cancer biomarkers market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
No comments:
Post a Comment